How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDTRONIC INC via MEDTRONIC, INC.
2016 · third_quarter · Q3
International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico. Issues related to the Treasury Department's proposed regulations on Section 385. Issues related to the continued suspension of the medical device tax. Issues related to state taxation.
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
Source: Senate LDA
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
Puerto Rico Oversight, Management, and Economic Stability Act
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico. H.R. 5278 - Puerto Rico Oversight Management and Economic Stability Act (PROMESA) - provisions concerning the financial status of Puerto Rico. Issues related to the Treasury Departments' proposed regulations on Section 385. Issues related to the continued suspension of the medical device tax.
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Combination Product Regulatory Fairness Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Combination Product Regulatory Fairness Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Combination Product Regulatory Fairness Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
Combination Product Regulatory Fairness Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Patient Access to Durable Medical Equipment Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
Patient Access to Durable Medical Equipment Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
National Defense Authorization Act for Fiscal Year 2017
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
S. 2943 - National Defense Act - provisions related to cybersecurity.
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
Advancing Research for Neurological Diseases Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Advancing Research for Neurological Diseases Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Advancing Research for Neurological Diseases Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Advancing Research for Neurological Diseases Act of 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
A resolution designating September 2016 as "National Brain Aneurysm Awareness Month".
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
A resolution designating September 2016 as "National Brain Aneurysm Awareness Month".
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
Food and Drug Administration Safety Over Sequestration Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. H.R.160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. Issues related to the 21st century cures draft, medical innovation and technology. Issues related to neuroscience research. Issues related to remote patient management and telehealth. Issues related to the humanitarian device exemption(HDE)/patient cap.
Food and Drug Administration Safety Over Sequestration Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to neuroscience research. Issues related to remote patient management and telehealth.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. H.R.160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. Issues related to the 21st century cures draft, medical innovation and technology. Issues related to neuroscience research. Issues related to remote patient management and telehealth. Issues related to the humanitarian device exemption(HDE)/patient cap.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
National Defense Authorization Act for Fiscal Year 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations
National Defense Authorization Act for Fiscal Year 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations
National Defense Authorization Act for Fiscal Year 2016
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act - provisions related to the repeal of the medical device tax.
Medicare Access and CHIP Reauthorization Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
Medicare Access and CHIP Reauthorization Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
To provide for reconciliation pursuant to section 2002 of the concurrent resolution on the budget for fiscal year 2016.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
To provide for reconciliation pursuant to section 2002 of the concurrent resolution on the budget for fiscal year 2016.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act - provisions related to the repeal of the medical device tax.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath.
Issues related to competitive bidding for DME and diabetes H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to neuroscience research. Issues related to remote patient management and telehealth.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to neuroscience research. Issues related to remote patient management and telehealth.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
Telehealth Innovation and Improvement Act of 2015
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
A concurrent resolution expressing the sense of Congress that the United States Postal Service should issue a commemorative stamp honoring the 50th anniversary of the three civil rights marches from Selma, Alabama to Montgomery, Alabama that took place over the course of several weeks in March 1965.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to neuroscience research. Issues related to remote patient management and telehealth.
A concurrent resolution expressing the sense of Congress that the United States Postal Service should issue a commemorative stamp honoring the 50th anniversary of the three civil rights marches from Selma, Alabama to Montgomery, Alabama that took place over the course of several weeks in March 1965.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. H.R.160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. Issues related to the 21st century cures draft, medical innovation and technology. Issues related to neuroscience research. Issues related to remote patient management and telehealth. Issues related to the humanitarian device exemption(HDE)/patient cap.
A concurrent resolution expressing the sense of Congress that the United States Postal Service should issue a commemorative stamp honoring the 50th anniversary of the three civil rights marches from Selma, Alabama to Montgomery, Alabama that took place over the course of several weeks in March 1965.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise tax
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise tax
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to Medicare reimbursement P.L. 113-46 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions related to Medicare reimbursement and FDA funding H.R. 3547 - 2014 Consolidated Appropriations Act - provisions related to Medicare reimbursement and FDA funding
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to Medicare reimbursement P.L. 113-46 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions related to Medicare reimbursement and FDA funding H.R. 3547 - 2014 Consolidated Appropriations Act - provisions related to Medicare reimbursement and FDA funding
Transparency and Accountability in Medicare Bidding Act of 2013
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
Transparency and Accountability in Medicare Bidding Act of 2013
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to Round One recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.H.R. 2725 - FDA Safety Over Sequestration Act of 2013, and S. 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration H.R. 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like abdominal aortic aneurysm, hypertension screenings. H.R. 3077 The TELE-MED Act of 2013 provisions related to telemedicine and remote monitoring that increase access to health care and enhance patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of health information technology and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Transparency and Accountability in Medicare Bidding Act of 2013
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research
Transparency and Accountability in Medicare Bidding Act of 2013
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to Round One recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.Provided continuing support for Medtronic acquisition of Covidien, which included attention to potential legislation on federal contracting limitations and various tax policy proposals. H.R. 2725 - FDA Safety Over Sequestration Act of 2013, and S. 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration H.R. 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like abdominal aortic aneurysm, hypertension screenings. H.R. 3077 The TELE-MED Act of 2013 provisions related to telemedicine and remote monitoring that increase access to health care and enhance patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of health information technology and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Transparency and Accountability in Medicare Bidding Act of 2013
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned EntitiesIssues relating to remote patient management and telehealth S. 2689 & H.R. 5644 - Medicare CGM Access Act of 2014 - provisions related to continuous glucose monitoring H.R. 5380 - Medicare Telehealth Parity Act of 2014 - provisions that expand definition of telehealth into remote patient monitoring in chronic conditions
Transparency and Accountability in Medicare Bidding Act of 2013
Client: MEDTRONIC INC · Firm: MEDTRONIC, INC.
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardH.R. 4302 - Protecting Access to Medicare Act of 2014 - provisions related to supporting permanent fix of the sustainable growth rate formula HR 4015 The SGR Repeal & Medicare Provide Payment Modernization Act of 2014 Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month." H.R. 5325 - Short-Term Continuing Resolution - provisions related to opioid funding. Issues related to VA procurement and devices.
Issues related to the negotiation of the Trans-Pacific Partnership Agreement. Issues related to India market access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via MEDTRONIC, INC.
2016 · second_quarter · Q2
H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.
S. 2943 - National Defense Act - provisions related to cybersecurity.
International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico. H.R. 5278 - Puerto Rico Oversight Management and Economic Stability Act (PROMESA) - provisions concerning the financial status of Puerto Rico. Issues related to the Treasury Departments' proposed regulations on Section 385. Issues related to the continued suspension of the medical device tax.
Issues related to the negotiation of the Trans-Pacific Partnership Agreement. Issues related to India market access.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. H.R. 4155/S.2343 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2187 - FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions related to combination product issues. S. 2737 - Improving Medical Device Innovation Act - provisions related to medical device innovation. S. 524 - Comprehensive Addiction and Recovery Act of 2016 - provisions related to pain management. S. 2998/H.R. 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016. S. Res. 438 - Designating September 2016 as "National Brain Aneurysm Awareness Month."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via MEDTRONIC, INC.
2016 · first_quarter · 1A
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues relating to India market access.
International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via MEDTRONIC, INC.
2016 · first_quarter · Q1
International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico.
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues relating to India market access.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath. S. 2187- FDA Regulatory Efficiency Act, Efforts - provisions in support of third-party quality system programs. S. 1622 - The FDA Device Accountability Act of 2015 - provisions in support for centralized IRBs. S. 849 - Neurological Disease Act - provisions promoting research and aggregation of data on neurological diseases. S. 1767 - The Combination Product Regulatory Fairness Act - provisions relating to clarification of processes around approval and GMPs of combination products. S. 2737 - Improving Medical Device Innovation Act - provisions relating to medical device innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via MEDTRONIC, INC.
2015 · fourth_quarter · Q4
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act - provisions related to the repeal of the medical device tax.
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement.
H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to remote patient management and telehealth. H.R. 4155 - Telehealth Innovation and Improvement Act of 2015 - provisions related to remote patient management and telehealth. S. 2343 - Teleheath Innovation and Improvement Act of 2015 - provisions related to remote patient management and teleheath.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via MEDTRONIC, INC.
2015 · third_quarter · Q3
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
MEDTRONIC INC via MEDTRONIC, INC.
2015 · second_quarter · Q2
H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues related to statutory extension of Trade Promotion Authority. Issues that promote the competitiveness of the U.S. healthcare sector in international markets.
MEDTRONIC INC via MEDTRONIC, INC.
2015 · first_quarter · Q1
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. H.R.160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. Issues related to the 21st century cures draft, medical innovation and technology. Issues related to neuroscience research. Issues related to remote patient management and telehealth. Issues related to the humanitarian device exemption(HDE)/patient cap.
S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.
MEDTRONIC INC via MEDTRONIC, INC.
2014 · fourth_quarter · Q4
Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned EntitiesIssues relating to remote patient management and telehealth S. 2689 & H.R. 5644 - Medicare CGM Access Act of 2014 - provisions related to continuous glucose monitoring H.R. 5380 - Medicare Telehealth Parity Act of 2014 - provisions that expand definition of telehealth into remote patient monitoring in chronic conditions
S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise tax; H.R. 83 - FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act - provisions related to inversion federal contract ban. Provided continuing support for Medtronic's acquisition of Covidien, which included attention to potential legislation on federal contracting limitations.
MEDTRONIC INC via MEDTRONIC, INC.
2014 · third_quarter · Q3
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise tax
Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned EntitiesIssues relating to remote patient management and telehealth S. 2689 & H.R. 5644 - Medicare CGM Access Act of 2014 - provisions related to continuous glucose monitoring H.R. 5380 - Medicare Telehealth Parity Act of 2014 - provisions that expand definition of telehealth into remote patient monitoring in chronic conditions
MEDTRONIC INC via MEDTRONIC, INC.
2014 · first_quarter · 1A
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research
MEDTRONIC INC via MEDTRONIC, INC.
2014 · second_quarter · Q2
S. 2360 & H.R. 4679 - Stop Corporate Inversion Act of 2014 - provisions related to US companies merging with foreign companies and reincorporating in foreign jurisdictions S. 2260 - Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit;Tax Reform Act of 2014 - provisions related to R&D credit, international tax issues, including the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals Information sharing regarding the June 15, 2014 announcement by Medtronic that the company entered into a definitive agreement to acquire healthcare technology and medical supplies provider Covidien
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise tax
MEDTRONIC INC via MEDTRONIC, INC.
2014 · first_quarter · Q1
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to Medicare reimbursement P.L. 113-46 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions related to Medicare reimbursement and FDA funding H.R. 3547 - 2014 Consolidated Appropriations Act - provisions related to Medicare reimbursement and FDA funding
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardH.R. 4302 - Protecting Access to Medicare Act of 2014 - provisions related to supporting permanent fix of the sustainable growth rate formula HR 4015 The SGR Repeal & Medicare Provide Payment Modernization Act of 2014 Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
MEDTRONIC INC via MEDTRONIC, INC.
2013 · fourth_quarter · Q4
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete. HR 2810 - the Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of SGR HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestrationHR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to remote monitoring that increase access to health care H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile applications Issues related to neuroscience research
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to Medicare reimbursement P.L. 113-46 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions related to Medicare reimbursement and FDA funding H.R. 3547 - 2014 Consolidated Appropriations Act - provisions related to Medicare reimbursement and FDA funding
MEDTRONIC INC via MEDTRONIC, INC.
2013 · third_quarter · 3A
S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax Issues related to the R & D tax credit and corporate tax reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals
HR 2375, Transparency and Accountability in Medicare Bidding Act of 2013, provisions relating to round one recompete. HR 2810, the Medicare Patient Access and Quality Improvement Act of 2013 and issues relating to reform of SGR HR 2725, FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act, protecting industry paid user fees from sequestrationHR 2663 & S. 1422 - The Preventative Health Savings Act, provisions that will permit leaders in Congress request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. Issues related to FDA regulation of HIT and mobile applications Issues related to neuroscience research
MEDTRONIC INC via MEDTRONIC, INC.
2013 · third_quarter · Q3
HR 2375, Transparency and Accountability in Medicare Bidding Act of 2013, provisions relating to round one recompete. HR 2810, the Medicare Patient Access and Quality Improvement Act of 2013 and issues relating to reform of SGR HR 2725, FDAf Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act, protecting industry paid user fees from sequestrationHR 2663 & S. 1422 - The Preventative Health Savings Act, provisions that will permit leaders in Congress request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysms or Hypertension screenings. Issues related to FDA regulation of HIT and mobile applications Issues related to neuroscience research
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board. S. 351, Protecting Seniors Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory BoardIssues related to competitive bidding for DME products including HR 2375, the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to coverage of continuous glucose monitoring devices were relayed to House Diabetes Caucus Leadership H. Con. Res. 25 - House Budget - provisions relating to HHS funding, including Medicare reimbursement S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement P.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement Issues relating to competitive bidding for DME products Issues relating to amending title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians services, and for other purposes
MEDTRONIC INC via MEDTRONIC, INC.
2013 · second_quarter · Q2
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board. S. 351, Protecting Seniors Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory BoardH. Con. Res. 25 - House Budget - provisions relating to HHS funding, including Medicare reimbursement S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement P.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement Issues relating to competitive bidding for DME products Issues relating to amending title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians services, and for other purposes
S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to the repeal of the medical device tax Issues related to the R & D tax credit and Corporate Tax Reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals
MEDTRONIC INC via MEDTRONIC, INC.
2013 · first_quarter · Q1
S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to the repeal of the medical device tax Issues related to the R & D tax credit and Corporate Tax Reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory BoardH. Con. Res. 25 - House Budget - provisions relating to HHS funding, including Medicare reimbursement S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement P.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement Issues relating to competitive bidding
MEDTRONIC INC via MEDTRONIC, INC.
2012 · fourth_quarter · Q4
P.L. 112-25 - Budget Control Act of 2011 - provisions relating to Medicare reimbursement P.L. 112-175 - (H.J. Resolution 117) - Continuing Appropriations Resolution, 2013 P.L. 112-25 - Budget Control Act - provisions relating to the sequestration of Medicare and FDA. P.L. 112-240 (H.R. 8), The American Taxpayer Relief Act of 2012 - Provisions relating to Medicare reimbursements and sequestration Issues related to FY13 funding for the Food and Drug Administration
S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax S. 3521, The Family & Business Tax Cut Certainty Act of 2012 - Provisions relating to the extension of the R&D tax credit. P.L. 112-240 (H.R. 8), The American Taxpayer Relief Act of 2012 - Provisions relating to the medical device tax and the R& D tax credit. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
MEDTRONIC INC via MEDTRONIC, INC.
2012 · third_quarter · Q3
P.L. 112-25 - Budget Control Act - provisions relating to the sequestration of Medicare. H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012 - (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the physician fee schedule H.R. 5 - Protecting Access to Healthcare Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board H.R. 452 - Medicare Decisions Accountability Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board S. 2118 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board Issues concerning DMEPOS competitive bidding and new external infusion pumps and supplies product category Congressional oversight and investigations issues related to physician-owned entities
P.L. 111-148 - Patient Protection and Affordable Health Care Act - provisions relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues P.L. 112-144 - the Food and Drug Administration Safety and Innovation Act - provisions relating to the implementation of this Act including the medical device user fee program S. 3187 - Food and Drug Administration Reform Act of 2012 - provisions relating to medical device user fees H.R. 5651 - Food and Drug Administration Reform Act of 2012 - provisions relating to medical device user fees S. 2516 - the Food and Drug Administration Safety and Innovation Act - provisions relating to medical device user fees
MEDTRONIC INC via MEDTRONIC, INC.
2012 · second_quarter · Q2
S. 365 - Budget Control Act of 2011 - provisions relating to Medicare reimbursement
S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement H.R. 3630 - Middle Class Tax Relief and Job Creation Act (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the R & D tax credit Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
MEDTRONIC INC via MEDTRONIC, INC.
2012 · first_quarter · Q1
S. 365 - Budget Control Act of 2011 - provisions relating to Medicare reimbursement
S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax S. 262 - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax H.R. 488 - Save Our Medical Devices Act of 2011 - provisions relating to the repeal of the medical device excise tax H.R. 734 - provisions relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement H.R. 3630 - Middle Class Tax Relief and Job Creation Act (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the R & D tax credit Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · fourth_quarter · Q4
Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - Provisions relating to regulatory and tax improvement H.R. 3211 - Humanitarian Device Reform Act of 2011 - Improve humanitarian device regulation and foster device development for rare diseases. S. 1865 - Patient Access to Medical Innovation Act - Improve humanitarian device regulation and foster device development for rare diseases. H.R. 3209 - Premarket Predictability Act of 2011 - Provisions relating to a new streamlined review of new devices, require reviewers to provide scientific or regulatory rationale for major decisions and establish an expedited approval appellate process, and the establishment of the two Investigational Device Exemption pathways. H.R. 3203 - Novel Device Regulatory Relief Act of 2011 - Streamlines the de novo classification process by striking the requirement that an applicant submit a 510(k) application before entering the de novo process. H.R. 3206 - Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Fixes the FDA's conflict of interest policies to ensure the most knowledgeable experts are able to serve on FDA advisory committees. H.R. 3214 - Food and Drug Amdinistration Mission Reform Act of 2011 - establishes a regulatory system that is accessible, consistent and transparent, promotes predictability, allows flexibility and reduces uncertainty, facilitates innovation, protects public health and enables patients accessto novel products, and incorporates a patient-focused, risk-benefit framework to ensure the FDA takes them into account. H.R. 3205 - FDA Renewing Efficiency From Outside Reviewer Management Act of 2011 - Reauthorizes the third party inspection program and reforms the third party review program to foster better participation, decrease approval times and conserve FDA resources. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · third_quarter · 3A
Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement Humanitarian Device Reform legislation to foster device development for rare diseases. Issues relating to group purchasing organizations. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · second_quarter · 2A
H.R. 658/S. 233 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries
Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax Issues relating to group purchasing organizations. Issues relating to the FDA 510(k) review process for medical devices.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · third_quarter · Q3
H.R. 658/S. 233 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries Amendment to H.R. 658 prohibiting the promulgation of regulations related to lithium batteries. Final Rule regarding transportation of lithium batteries (RIN: 2137-AE44)
H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform. S. 365 - Budget Control Act of 2011 as it relates to Medicare reimbursement.
Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement Humanitarian Device Reform legislation to foster device development for rare diseases. Issues relating to group purchasing organizations. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · second_quarter · Q2
H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform. S. 365 - Budget Control Act of 2011 as it relates to Medicare reimbursement.
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · second_quarter · Q2
H.R. 658/S. 233 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries
H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform.
Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax Issues relating to group purchasing organizations. Issues relating to the FDA 510(k) review process for medical devices.
MEDTRONIC INC via MEDTRONIC, INC.
2011 · first_quarter · Q1
H.R. 658 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
MEDTRONIC INC via MEDTRONIC, INC.
2010 · fourth_quarter · Q4
Issues related to the taxation of foreign earnings of U.S. corporations. H.R. 4213 - the Tax Extenders Act, as it relates to the research and development tax credit. S. 3816, Creating American Jobs and Ending Offshoring Act; HR 5982, The Small Business Tax Relief Act; HR 5793, Close Foreign Tax Loopholes Act; and HR 5893, Investing in American Jobs Act, as they relate to the taxation of foreign earnings of U.S. corporations. HR 4213, the Tax Extenders Act; HR 5297, the Small Business Jobs and Credit Act; and S. 3793, the Job Creation and Tax Cuts Act, as they relate to the research and development tax credit.
H.R. 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. H.R. 2749 - Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 759 - FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 4994 -- The Medicare and Medicaid Extenders Act of 2010 - section 112 - reauthorization of the Special Diabetes Program. Patient Protection and Affordable Care Act [P.L. 111-148] - Implementation issues concerning CER, IPAB, excise tax, prevention and wellness, disparaties, pain, payment reform provisions.
MEDTRONIC INC via MEDTRONIC, INC.
2010 · third_quarter · Q3
H.R. 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. H.R. 2749 - Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 759 - FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions Patient Protection and Affordable Care Act [P.L. 111-148] - Implementation issues concerning CER, IPAB, excise tax, prevention and wellness, disparaties, pain, payment reform provisions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), White House Office
MEDTRONIC INC via MEDTRONIC, INC.
2010 · second_quarter · Q2
H.R. 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. H.R. 2749 - Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 759 - FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to competitive bidding for DME and diabetes H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to neuroscience research. Issues related to remote patient management and telehealth.
Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues that promote the competitiveness of the U.S. healthcare sector in international markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. H.R.6 - 21st Century Cures Act - provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to neuroscience research. Issues related to remote patient management and telehealth.
H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to the physician fee schedule and the SGR formula. H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to Round One recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.Provided continuing support for Medtronic acquisition of Covidien, which included attention to potential legislation on federal contracting limitations and various tax policy proposals. H.R. 2725 - FDA Safety Over Sequestration Act of 2013, and S. 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration H.R. 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like abdominal aortic aneurysm, hypertension screenings. H.R. 3077 The TELE-MED Act of 2013 provisions related to telemedicine and remote monitoring that increase access to health care and enhance patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of health information technology and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to Round One recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.H.R. 2725 - FDA Safety Over Sequestration Act of 2013, and S. 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration H.R. 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like abdominal aortic aneurysm, hypertension screenings. H.R. 3077 The TELE-MED Act of 2013 provisions related to telemedicine and remote monitoring that increase access to health care and enhance patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of health information technology and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardH.R. 4302 - Protecting Access to Medicare Act of 2014 - provisions related to supporting permanent fix of the sustainable growth rate formula HR 4015 The SGR Repeal & Medicare Provide Payment Modernization Act of 2014 Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
H. Con. Res. 25 - House Budget - provisions related to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to Medicare reimbursement P.L. 113-46 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions related to Medicare reimbursement and FDA funding H.R. 3547 - 2014 Consolidated Appropriations Act - provisions related to Medicare reimbursement and FDA funding
S. 232 - Medical Device Access and Innovation Protection Act - provisions related to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions related to the repeal of the medical device excise tax Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit, and repeal of the medical device excise taxTax Reform Act of 2014 - provisions related to R&D credit, international tax issues, including the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals S. 1859 - Tax Extenders Act of 2013 - provisions related to extension of expiring tax provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research
S. 232 - Medical Device Access and Innovation Protection Act - provisions related to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions related to the repeal of the medical device excise tax Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit, and repeal of the medical device excise taxTax Reform Act of 2014 - provisions related to R&D credit, international tax issues, including the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals S. 1859 - Tax Extenders Act of 2013 - provisions related to extension of expiring tax provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 232 - Medical Device Access and Innovation Protection Act - provisions related to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions related to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to the repeal of the medical device excise tax Issues related to the R & D tax credit and corporate tax reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardIssues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to Medicare coverage of continuous glucose monitoring devices H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board. S. 351, Protecting Seniors Access to Medicare Act of 2013 - provisions relating to the repeal of the Medicare Independent Payment Advisory BoardIssues related to competitive bidding for DME products including HR 2375, the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to Medicare coverage of continuous glucose monitoring devices H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to HHS funding, including Medicare reimbursement Issues relating to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities
H. Con. Res. 25 - House Budget - provisions relating to HHS funding, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement and FDA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to the repeal of the medical device tax Issues related to the R & D tax credit and Corporate Tax Reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals
H. Con. Res. 25 - House Budget - provisions relating to HHS fundings, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement and the medical device tax P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement and FDA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res. 25 - House Budget - provisions relating to HHS fundings, including Medicare reimbursement and FDA funding H.R. 2410 Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S.1244 - Agriculture, Rural Development, FDA Appropriations Act - provisions related to FY13 & FY14 funding for the FDA S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement and the medical device tax P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement and FDA funding
HR 2375, Transparency and Accountability in Medicare Bidding Act of 2013, provisions relating to round one recompete. Issues related to mobile medical applications and neuroscience research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to mobile medical applications, competitive bidding, Medicare diabetic coverage and neuroscience research
H. Con. Res. 25 - House Budget - provisions relating to HHS fundings, including Medicare reimbursement and FDA funding S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to Medicare reimbursement and the medical device tax P.L. 113-6 - Consolidated and Further Continuing Appropriations Act, 2013 - provisions relating to Medicare reimbursement and FDA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
P.L. 111-148 - Patient Protection and Affordable Health Care Act - provisions relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues P.L. 112-144 - the Food and Drug Administration Safety and Innovation Act - provisions relating to the implementation of this Act including the medical device user fee program
P.L. 112-25 - Budget Control Act - provisions relating to the sequestration of Medicare. H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012 - (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the physician fee schedule H.R. 5 - Protecting Access to Healthcare Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board H.R. 452 - Medicare Decisions Accountability Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board S. 2118 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board P.L. 112-240 (H.R. 8), The American Taxpayer Relief Act of 2012 - Provisions relating to medical reimbursement, Medicare sequestration and updates to the Medicare Sustainable Growth rate formula for physicians and related issues. Issues concerning DMEPOS competitive bidding and new external infusion pumps and supplies product category Congressional oversight and investigations issues related to physician-owned entities
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax S. 3521, The Family & Business Tax Cut Certainty Act of 2012 - Provisions relating to the extension of the R&D tax credit. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
P.L. 112-25 - Budget Control Act of 2011 - provisions relating to Medicare reimbursement P.L. 112-175 - (H.J. Resolution 117) - Continuing Appropriations Resolution, 2013 P.L. 112-25 - Budget Control Act - provisions relating to the sequestration of Medicare and FDA. Issues related to FY13 funding for the Centers for Medicare and Medicaid Services, and the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012 (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the physician fee schedule Congressional oversight and investigations issues related to physician-owned entities H.R. 5 - Protecting Access to Healthcare Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board H.R. 452 - Medicare Decisions Accountibility Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board S. 2118 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board
Patient Protection and Affordable Health Care Act (P.L. 111-148) - provisions relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues H.R. 3211 - Humanitarian Device Reform Act of 2011 - provisions relating to improving of humanitarian device regulation and foster device development for rare diseases S. 1865 - Patient Access to Medical Innovation Act - provisions relating to improving humanitarian device regulation and foster device development for rare diseases H.R. 3209 - Premarket Predictability Act of 2011 - provisions relating to a new streamlined review of new devices, require reviewers to provide scientific or regulatory rationale for major decisions and establish an expedited approval appellate process, and the establishment of the two Investigational Device Exemption pathways H.R. 3203 - Novel Device Regulatory Relief Act of 2011 - provisions relating to the streamlining the de novo classification process by striking the requirement that an applicant submit a 510(k) application before entering the de novo process H.R. 3206 - Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - provisions relating to the fixing of the FDA's conflict of interest policies to ensure the most knowledgeable experts are able to serve on FDA advisory committees H.R. 3847 - Safety of Untested and New Devices Act of 2012 - provisions relating to predicate nullification S. 2193 - Ensuring Safe Medical Devices for Patients - provisions relating to requiring the Food and Drug Administration to include devices in the postmarket risk identification and analysis system, to expedite the implementation of the unique device identification system for medical devices, and for other purposes S. 1995 - Medical Device Patient Safety Act - provisions relating to enhancing the Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes H.R. 3975 - Pediatric Medical Device Safety and Improvement Act - provisions relating to the continued availability of pediatric devices under the FDA humanitarian use device program. S. 2289 - The Better Pharmaceuticals and Devices Act for Children - provisions relating to the reauthorization of the Pediatric Device Consortia Initiative and to the continued availability of pediatric devices under the FDA humanitarian use device program. S. 3187 - Food and Drug Administration Reform Act of 2012, Public Law 112-144 - provisions relating to medical device user fees S. 2516 - Food and Drug Administration Safety and Innovation Act - provisions relating to medical device user fees H.R. 5651 - Food and Drug Administration Reform Act of 2012 - provisions relating to medical device user fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 658 - FAA Modernization and Reform Act of 2012 - provisions relating to the air shipment of lithium batteries S. 223 - FAA Air Transportation Modernization and Safety Improvement Act - provisions relating to the air shipment of lithium batteries Final Rule regarding transportation of lithium batteries (RIN: 2137-AE44)
Patient Protection and Affordable Health Care Act (P.L. 111-148) - provisions relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues H.R. 3211 - Humanitarian Device Reform Act of 2011 - provisions relating to the improving of humanitarian device regulation and foster device development for rare diseases S. 1865 - Patient Access to Medical Innovation Act - provisions relating to the improving humanitarian device regulation and foster device development for rare diseases H.R. 3209 - Premarket Predictability Act of 2011 - provisions relating to a new streamlined review of new devices, require reviewers to provide scientific or regulatory rationale for major decisions and establish an expedited approval appellate process, and the establishment of the two Investigational Device Exemption pathways H.R. 3203 - Novel Device Regulatory Relief Act of 2011 - provisions relating to the streamlining the de novo classification process by striking the requirement that an applicant submit a 510(k) application before entering the de novo process H.R. 3206 - Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - provisions relating to the fixing of the FDA's conflict of interest policies to ensure the most knowledgeable experts are able to serve on FDA advisory committees H.R. 3847 - Safety of Untested and New Devices Act of 2012 - provisions relating to predicate nullification S. 2193 - Ensuring Safe Medical Devices for Patients - provisions relating to requiring the Food and Drug Administration to include devices in the postmarket risk identification and analysis system, to expedite the implementation of the unique device identification system for medical devices, and for other purposes S. 1995 - Medical Device Patient Safety Act - provisions relating to enhancing the Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes H.R. 3975 - Pediatric Medical Device Safety and Improvement Act - provisions relating to the continued availability of pediatric devices under the FDA humanitarian use device program.
H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012 (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the physician fee schedule Congressional oversight and investigations issues related to physician-owned entities H.R. 5 - Protecting Access to Healthcare Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board H.R. 452 - Medicare Decisions Accountibility Act - provisions relating to the repeal of the Medicare Independent Payment Advisory Board S. 2118 - provisions relating to the repeal of the Medicare Independent Payment Advisory Board
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. H.R. 3630 - Temporary Payroll Tax Cut Continuation Act - issues relating to the R & D tax credit H.R. 3765 - Temporary Payroll Tax Cut Continuation Act - issues relating to the R & D tax credit H.R. 3123 - American Job Creation & Investment Act - issues relating R & D tax credit S. 1660 - American Jobs Act - issues relating R & D tax credit S. 1549 - American Jobs Creation Act - issues relating R & D tax credit Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
H.R. 658/S. 233 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries Amendment to H.R. 658 prohibiting the promulgation of regulations related to lithium batteries. Final Rule regarding transportation of lithium batteries (RIN: 2137-AE44)
H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform. S. 365 - Budget Control Act of 2011 as it relates to Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform. S. 365 - Budget Control Act of 2011 as it relates to Medicare reimbursement.
H.R. 658/S. 233 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries Amendment to H.R. 658 prohibiting the promulgation of regulations related to lithium batteries. Final Rule regarding transportation of lithium batteries (RIN: 2137-AE44)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 658/S. 233 - FAA Air Transportation Modernization and Safety Improvement Act - Concerned with the section that relates to the air shipment of lithium batteries Amendment to H.R. 658 prohibiting the promulgation of regulations related to lithium batteries. Final Rule regarding transportation of lithium batteries (RIN: 2137-AE44)
Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement Humanitarian Device Reform legislation to foster device development for rare diseases. Issues relating to group purchasing organizations. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Patient Protection and Affordable Care Act (P.L. 111-148) - Issues relating to the implemention of this Act including Accountable Care Organizations, Sunshine Act, Patient-Centered Outcomes Research Institute (PCORI) and other issues. Issues relating to the FDA 510(k) review process for medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), White House Office